Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.48 |
| ▸ | CES1 | P23141 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PDE2A | O00408 | 1/20 | 0.47 |
| ▸ | KIF11 | P52732 | 6/20 | 0.46 |
| ▸ | ACP3 | P15309 | 1/20 | 0.45 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.44 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.44 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.44 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26438529 | 0.88 | KIF11 (0.64) | CES2CES1TSHRKIF11ACP3 | |
| SCHEMBL22402545 | 0.88 | TRPV1 (0.46) | CES2CES1ALDH1A1TSHRPDE2A | |
| SCHEMBL25122169 | 0.88 | CYP19A1 (0.47) | CES2CES1ALDH1A1TSHRPDE2A | |
| SCHEMBL31409220 | 0.88 | KIF11 (0.64) | CES2CES1ALDH1A1TSHRPDE2A | |
| SCHEMBL20465824 | 0.88 | PDE2A (0.44) | CES2CES1ALDH1A1TSHRPDE2A | |
| SCHEMBL13382016 | 0.84 | KIF11 (0.68) | ALDH1A1TSHRKIF11ACP3 | |
| SCHEMBL11540603 | 0.81 | SLC6A3 (0.69) | ALDH1A1TSHRKIF11ACP3 | |
| SCHEMBL63468 | 0.80 | ALDH1A1 (0.67) | CES2CES1ALDH1A1TSHRKIF11 | |
| SCHEMBL7643556 | 0.80 | CES2 (0.47) | CES2CES1ALDH1A1TSHRPDE2A | |
| SCHEMBL26437522 | 0.79 | KIF11 (0.53) | CES2CES1TSHRPDE2AKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3475995-B1 | QUANTUM DOT LIGHT EMITTING DEVICES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2022-12-21 | — | — | EP | disclosed |
| US-20210210691-A1 | POLYMERIC LAYER AND ORGANIC ELECTRONIC DEVICE COMPRISING SAME. | DOW GLOBAL TECHNOLOGIES LLC (US) | 2021-07-08 | — | — | US | disclosed |
| US-10818860-B2 | Quantum dot light emitting devices | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2020-10-27 | — | — | US | disclosed |
| US-20200066993-A1 | POLYMERIC CHARGE TRANSFER LAYER AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2020-02-27 | — | — | US | disclosed |
| US-20190334106-A1 | QUANTUM DOT LIGHT EMITTING DEVICES | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2019-10-31 | — | — | US | disclosed |
| US-10454036-B2 | Polymeric charge transfer layer and organic electronic device containing the same | DOW GLOBAL TECHNOLOGIES LLC (US) | 2019-10-22 | — | — | US | disclosed |
| EP-2380567-B1 | MELANIN PRODUCTION INHIBITOR | POLA CHEM IND INC (JP) | 2019-01-16 | — | — | EP | disclosed |
| US-20180226584-A1 | POLYMERIC CHARGE TRANSFER LAYER AND ORGANIC ELECTRONIC DEVICE CONTAINING THE SAME | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-08-09 | — | — | US | disclosed |
| WO-2018089181-A1 | ORGANIC INDOLYL TRIARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES COMPRISING AN ORGANIC LAYER CONTAINING SUCH COMPOUNDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-05-17 | — | — | WO | disclosed |
| WO-2018089181-A1 | ORGANIC INDOLYL TRIARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES COMPRISING AN ORGANIC LAYER CONTAINING SUCH COMPOUNDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-05-17 | — | — | WO | disclosed |
| US-20110243865-A1 | MELANIN PRODUCTION INHIBITOR | POLA CHEMICAL INDUSTRIES INC. (JP) | 2011-10-06 | — | — | US | disclosed |
| EP-2048168-A2 | Process for producing catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | Sumitomo Chemical Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-2048170-A2 | Second catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | Sumitomo Chemical Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-2048167-A2 | First catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | Sumitomo Chemical Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-2048169-A2 | Third catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | Sumitomo Chemical Company, Limited (JP) | 2009-04-15 | — | — | EP | disclosed |
| US-6914108-B2 | Catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-07-05 | — | — | US | disclosed |
| US-20030203810-A1 | Catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-10-30 | — | — | US | disclosed |
| US-6586356-B2 | Coordination catalyst | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-07-01 | — | — | US | disclosed |
| US-20010020075-A1 | Catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-09-06 | — | — | US | disclosed |
| EP-1113026-A2 | Catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-07-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10454036-B2 | Polymeric charge transfer layer and organic electronic device containing the same | CLTB, CYBA, L1CAM | CES2 1851/4885CES1 4809/4885ALDH1A1 1599/4885 |
| US-20180226584-A1 | POLYMERIC CHARGE TRANSFER LAYER AND ORGANIC ELECTRONIC DEVICE CONTAINING THE SAME | CLTB, CYBA, L1CAM | CES2 1851/4885CES1 4809/4885ALDH1A1 1599/4885 |
| US-20110243865-A1 | MELANIN PRODUCTION INHIBITOR | TYR, F12, TH | CES2 1159/4885CES1 1000/4885ALDH1A1 1292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.